title: Soluble epoxide hydrolase gene deletion improves blood flow and reduces infarct size after cerebral ischemia in reproductively senescent female mice.
abstract: Soluble epoxide hydrolase (sEH), a key enzyme in the metabolism of vasodilatory epoxyeicosatrienoic acids (EETs), is sexually dimorphic, suppressed by estrogen, and contributes to underlying sex differences in cerebral blood flow and injury after cerebral ischemia. We tested the hypothesis that sEH inhibition or gene deletion in reproductively senescent (RS) female mice would increase cerebral perfusion and decrease infarct size following stroke. RS (15-18 month old) and young (3-4 month old) female sEH knockout (sEHKO) mice and wild type (WT) mice were subjected to 45 min middle cerebral artery occlusion (MCAO) with laser Doppler perfusion monitoring. WT mice were treated with vehicle or a sEH inhibitor t-AUCB at the time of reperfusion and every 24 h thereafter for 3 days. Differences in regional cerebral blood flow were measured in vivo using optical microangiography (OMAG). Infarct size was measured 3 days after reperfusion. Infarct size and cerebral perfusion 24 h after MCAO were not altered by age. Both sEH gene deletion and sEH inhibition increased cortical perfusion 24 h after MCAO. Neither sEH gene deletion nor sEH inhibition reduced infarct size in young mice. However, sEH gene deletion, but not sEH inhibition of the hydrolase domain of the enzyme, decreased infarct size in RS mice. Results of these studies show that sEH gene deletion and sEH inhibition enhance cortical perfusion following MCAO and sEH gene deletion reduces damage after ischemia in RS female mice; however this neuroprotection in absent is young mice.
authors: Department of Anesthesiology and Perioperative Medicine, The Knight Cardiovascular Institute, Oregon Health and Science University Portland, OR, USA.
authors: Kristen L
authors: KL
authors: Zuloaga
authors: Department of Anesthesiology and Perioperative Medicine, The Knight Cardiovascular Institute, Oregon Health and Science University Portland, OR, USA.
authors: Wenri
authors: W
authors: Zhang
authors: Department of Anesthesiology and Perioperative Medicine, The Knight Cardiovascular Institute, Oregon Health and Science University Portland, OR, USA.
authors: Natalie E
authors: NE
authors: Roese
authors: Department of Anesthesiology and Perioperative Medicine, The Knight Cardiovascular Institute, Oregon Health and Science University Portland, OR, USA.
authors: Nabil J
authors: NJ
authors: Alkayed
keywords: aging; cerebral ischemia; cerebrovascular; epoxyeicosatrienoic acids; soluble epoxide hydrolase; stroke
references: Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1552-7
references: 12574508
references: Clin Sci (Lond). 2014 Jul;127(2):77-89
references: 24428837
references: Endocrinology. 1992 Sep;131(3):1458-66
references: 1505477
references: Minerva Endocrinol. 2010 Jun;35(2):109-25
references: 20595939
references: Biol Reprod. 1984 Mar;30(2):352-62
references: 6704470
references: Mol Pharmacol. 2001 Aug;60(2):310-20
references: 11455018
references: Brain Res. 1998 Jun 15;796(1-2):296-8
references: 9689481
references: J Appl Physiol (1985). 2002 Jan;92(1):195-201
references: 11744660
references: J Neurosci. 2007 Apr 25;27(17):4642-9
references: 17460077
references: Lancet Neurol. 2008 Oct;7(10):915-26
references: 18722812
references: PLoS One. 2013 May 08;8(5):e62329
references: 23667467
references: Future Neurol. 2009 Mar 1;4(2):179-199
references: 19779591
references: Stroke. 2001 Mar;32(3):796-802
references: 11239204
references: Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):6013-8
references: 17389368
references: Am J Physiol Heart Circ Physiol. 2009 May;296(5):H1352-63
references: 19304946
references: J Cereb Blood Flow Metab. 2007 Dec;27(12):1931-40
references: 17440491
references: J Neuroendocrinol. 2012 Feb;24(2):319-30
references: 22053957
references: Exp Gerontol. 1994 May-Aug;29(3-4):275-83
references: 7925748
references: Stroke. 2008 May;39(5):1593-6
references: 18323494
references: Am J Pathol. 2009 Jun;174(6):2086-95
references: 19435785
references: Neurobiol Aging. 2010 Sep;31(9):1618-28
references: 18829137
references: Pharmacogenet Genomics. 2010 Feb;20(2):94-103
references: 20065888
references: Front Biosci. 2008 Jan 01;13:2833-41
references: 17981757
references: Exp Neurol. 2013 Nov;249:120-31
references: 23994069
references: Stroke. 1998 Jan;29(1):159-65; discussion 166
references: 9445346
references: J Cereb Blood Flow Metab. 2011 Feb;31(2):413-25
references: 20940729
references: J Cereb Blood Flow Metab. 2009 Aug;29(8):1475-81
references: 19471280
references: Brain Res. 2004 May 22;1008(2):147-54
references: 15145751
references: Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1558-63
references: 12574510
references: Endocrinology. 2001 Jan;142(1):43-8
references: 11145565
references: J Cereb Blood Flow Metab. 2013 Oct;33(10):1650-6
references: 23899929
references: Mol Endocrinol. 2012 Oct;26(10):1716-31
references: 22851703
references: Restor Neurol Neurosci. 2009;27(3):163-79
references: 19531872
references: Am J Physiol Heart Circ Physiol. 2010 Feb;298(2):H679-87
references: 20008276
references: J Biol Chem. 2000 Dec 22;275(51):40504-10
references: 11001943
references: J Cereb Blood Flow Metab. 2007 Sep;27(9):1553-62
references: 17311081
references: Br J Pharmacol. 2009 Jan;156(2):284-96
references: 19154430
references: Stroke. 1991 Nov;22(11):1389-93
references: 1750047
references: Stroke. 2014 May;45(5):1545-88
references: 24503673
references: Am J Physiol Cell Physiol. 2007 Mar;292(3):C996-1012
references: 16987999
references: Stroke. 2008 Jul;39(7):2073-8
references: 18369166
references: J Cardiovasc Pharmacol. 2005 Dec;46(6):842-8
references: 16306811
references: Lancet Neurol. 2012 Jan;11(1):82-91
references: 22172623
references: Front Biosci (Elite Ed). 2012 Jan 01;4:976-97
references: 22201929
references: Prostaglandins Other Lipid Mediat. 2010 Apr;91(3-4):68-84
references: 19545642